Richter S, Seah J-A, Pond GR, Gan HK, Mackenzie MJ, Hotte SJ, et al. Evaluation of second line and subsequent targeted therapies in metastatic renal cell cancer (mRCC) patients treated with first line cediranib. CUAJ [Internet]. 2014 Dec. 15 [cited 2026 May 1];8(11-12):398-402. Available from: https://cuaj.ca/index.php/journal/article/view/2426